Form 8-K Apogee Therapeutics, For: Apr 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Apogee Therapeutics board to lose two directors in May
April 24, 2026 4:22 PM EDTApogee Therapeutics Inc. (NASDAQ: APGE) announced that two board members will resign effective May 11, 2026. Andrew Gottesdiener, M.D. and Peter Harwin notified the board of directors on April 21, 2026, of their intention to step down.
The company stated that the resignations are... More
